Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Neurocritical Care
Published in: Neurocritical Care 1/2020

01-02-2020 | Care | Special Article

Clinical Performance Measures for Neurocritical Care: A Statement for Healthcare Professionals from the Neurocritical Care Society

Authors: Sarah Livesay, Herbert Fried, David Gagnon, Navaz Karanja, Abhijit Lele, Asma Moheet, Casey Olm-Shipman, Fabio Taccone, David Tirschwell, Wendy Wright, J. Claude Hemphill III, the Neurocritical Care Society

Published in: Neurocritical Care | Issue 1/2020

Login to get access

Abstract

Background

Performance measures are tools to measure the quality of clinical care. To date, there is no organized set of performance measures for neurocritical care.

Methods

The Neurocritical Care Society convened a multidisciplinary writing committee to develop performance measures relevant to neurocritical care delivery in the inpatient setting. A formal methodology was used that included systematic review of the medical literature for 13 major neurocritical care conditions, extraction of high-level recommendations from clinical practice guidelines, and development of a measurement specification form.

Results

A total of 50,257 citations were reviewed of which 150 contained strong recommendations deemed suitable for consideration as neurocritical care performance measures. Twenty-one measures were developed across nine different conditions and two neurocritical care processes of care.

Conclusions

This is the first organized Neurocritical Care Performance Measure Set. Next steps should focus on field testing to refine measure criteria and assess implementation.
Appendix
Available only for authorised users
Literature
1.
Medicine IO. Crossing the quality chasm: a new health system for the 21st Century. Washington (DC): Medicine IO; 2001.
2.
3.
Moheet AM, Livesay SL, Abdelhak T, et al. Standards for neurologic critical care units: a statement for healthcare professionals from the Neurocritical Care Society. Neurocrit Care. 2018;29(2):145–60.PubMedCrossRef
4.
Higgins A, Veselovskiy G, McKown L. Provider performance measures in private and public programs: achieving meaningful alignment with flexibility to innovate. Health Aff (Millwood). 2013;32(8):1453–61.CrossRef
5.
6.
7.
Spertus JA, Eagle KA, Krumholz HM, et al. American College of Cardiology and American Heart Association methodology for the selection and creation of performance measures for quantifying the quality of cardiovascular care. J Am Coll Cardiol. 2005;45(7):1147–56.PubMedCrossRef
8.
Stelfox HT, Boyd JM, Straus SE, Gagliardi AR. Developing a patient and family-centred approach for measuring the quality of injury care: a study protocol. BMC Health Serv Res. 2013;13:31.PubMedPubMedCentralCrossRef
9.
Brouwers MC, Kerkvliet K, Spithoff K, Consortium, A.N.S. The AGREE reporting checklist: a tool to improve reporting of clinical practice guidelines. BMJ. 2016;352:i1152.PubMedPubMedCentralCrossRef
10.
Guyatt GH, Oxman AD, Vist GE, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336(7650):924–6.PubMedPubMedCentralCrossRef
11.
Hemphill JC, Greenberg SM, Anderson CS, et al. Guidelines for the management of spontaneous intracerebral hemorrhage: a Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke. 2015;46(7):2032–60.PubMedCrossRef
12.
Ahmed N, Steiner T, Caso V, Wahlgren N. Recommendations from the ESO-Karolinska stroke update conference, Stockholm 13–15 November 2016. Eur Stroke J. 2017;2(2):95–102.PubMedPubMedCentralCrossRef
13.
Albers GW, Amarenco P, Easton JD, Sacco RL, Teal P. Antithrombotic and thrombolytic therapy for ischemic stroke: the seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest. 2004;126(3 Suppl):483S–512S.PubMedCrossRef
14.
Albers GW, Amarenco P, Easton JD, Sacco RL, Teal P. Antithrombotic and thrombolytic therapy for ischemic stroke: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition). Chest. 2008;133(6 Suppl):630S–69S.PubMedCrossRef
15.
Alonso de Lecinana M, Egido JA, Casado I, et al. Guidelines for the treatment of acute ischaemic stroke. Neurologia. 2014;29(2):102–22.PubMedCrossRef
16.
Bernard SA, Gray TW, Buist MD, et al. Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia. N Engl J Med. 2002;346(8):557–63.PubMedCrossRef
17.
Blackham KA, Meyers PM, Abruzzo TA, et al. Endovascular therapy of acute ischemic stroke: report of the Standards of Practice Committee of the Society of NeuroInterventional Surgery. J Neurointerv Surg. 2012;4(2):87–93.PubMedCrossRef
18.
Bonow RO, Bennett S, Casey DE Jr, et al. ACC/AHA clinical performance measures for adults with chronic heart failure: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Heart Failure Clinical Performance Measures) endorsed by the Heart Failure Society of America. J Am Coll Cardiol. 2005;46(6):1144–78.PubMedCrossRef
19.
Bonow RO, Bennett S, Casey DE Jr, et al. ACC/AHA clinical performance measures for adults with chronic heart failure: a report of the American College of Cardiology/American Heart Association task force on performance measures (writing committee to develop heart failure clinical performance measures): endorsed by the Heart Failure Society of America. Circulation. 2005;112(12):1853–87.PubMedCrossRef
20.
Brophy GM, Bell R, Claassen J, et al. Guidelines for the evaluation and management of status epilepticus. Neurocrit Care. 2012;17(1):3–23.PubMedCrossRef
21.
Brouwer MC, McIntyre P, Prasad K, van de Beek D. Corticosteroids for acute bacterial meningitis. Cochrane Database Syst Rev. 2015;9:CD004405.
22.
Bryer A, Connor M, Haug P, et al. South African guideline for management of ischaemic stroke and transient ischaemic attack 2010: a guideline from the South African Stroke Society (SASS) and the SASS Writing Committee. S Afr Med J. 2010;100(11 Pt 2):747–78.PubMedCrossRef
23.
Callaway CW, Donnino MW, Fink EL, et al. Part 8: post-cardiac arrest care: 2015 American Heart Association guidelines update for cardiopulmonary resuscitation and emergency cardiovascular care. Circulation. 2015;132(18 Suppl 2):S465–82.PubMedPubMedCentralCrossRef
24.
Cariou A, Payen JF, Asehnoune K, et al. Targeted temperature management in the ICU: guidelines from a French expert panel. Ann Intensive Care. 2017;7(1):70.PubMedPubMedCentralCrossRef
25.
Carney N, Totten AM, O’Reilly C, et al. Guidelines for the management of severe traumatic brain injury, fourth edition. Neurosurgery. 2017;80(1):6–15.CrossRefPubMed
26.
Casaubon LK, Boulanger JM, Blacquiere D, et al. Canadian Stroke best practice recommendations: hyperacute stroke care guidelines, update 2015. Int J Stroke. 2015;10(6):924–40.PubMedCrossRef
27.
Castren M, Silfvast T, Rubertsson S, et al. Scandinavian clinical practice guidelines for therapeutic hypothermia and post-resuscitation care after cardiac arrest. Acta Anaesthesiol Scand. 2009;53(3):280–8.PubMedCrossRef
28.
Chaudhuri A, Martinez-Martin P, Kennedy PGE, et al. EFNS guideline on the management of community-acquired bacterial meningitis: report of an EFNS Task Force on acute bacterial meningitis in older children and adults. Eur J Neurol. 2008;15(7):649–59.PubMedCrossRef
29.
Chevret S, Hughes RA, Annane D. Plasma exchange for Guillain–Barre syndrome. Cochrane Database Syst Rev. 2017;2:CD001798.PubMed
30.
Christensen AS, Roed C, Omland LH, et al. Long-term mortality in patients with tuberculous meningitis: a Danish nationwide cohort study. PLoS One. 2011;6(11):e27900.PubMedPubMedCentralCrossRef
31.
32.
Connolly ES, Rabinstein AA, Carhuapoma JR, et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2012;43(6):1711–37.PubMedCrossRef
33.
Cortese I, Chaudhry V, So YT, et al. Evidence-based guideline update: plasmapheresis in neurologic disorders: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology. 2011;76(3):294–300.PubMedPubMedCentralCrossRef
34.
Det Norske Veritas, Comprehensive Stroke Center Certification Program—Requirements. 2012: By request from DNV.
35.
Diringer MN, Bleck TP, Hemphill CJ, et al. Critical care management of patients following aneurysmal subarachnoid hemorrhage: recommendations from the Neurocritical Care Society’s Multidisciplinary Consensus Conference. Neurocrit Care. 2011;15(2):211–40.PubMedCrossRef
36.
Donnino MW, Andersen LW, Berg KM, et al. Temperature management after cardiac arrest: an advisory statement by the advanced life support task force of the International Liaison Committee on Resuscitation and the American Heart Association Emergency Cardiovascular Care Committee and the Council on cardiopulmonary, critical care, perioperative and resuscitation. Circulation. 2015;132(25):2448–56.PubMedCrossRef
37.
38.
Elovaara I, Apostolski S, van Doorn P, et al. EFNS guidelines for the use of intravenous immunoglobulin in treatment of neurological diseases: eFNS task force on the use of intravenous immunoglobulin in treatment of neurological diseases. Eur J Neurol. 2008;15(9):893–908.PubMedCrossRef
39.
European Stroke Organisation Executive, C. Committee, E.S.O.W. Guidelines for management of ischaemic stroke and transient ischaemic attack 2008. Cerebrovasc Dis. 2008;25(5):457–507.CrossRef
40.
Feasby T, Banwell B, Benstead T, et al. Guidelines on the use of intravenous immune globulin for neurologic conditions. Transfus Med Rev. 2007;21(2 Suppl 1):S57–107.PubMedCrossRef
41.
42.
Fried HI, Nathan BR, Rowe AS, et al. The insertion and management of external ventricular drains: an evidence-based consensus statement: a statement for healthcare professionals from the Neurocritical Care Society. Neurocrit Care. 2016;24(1):61–81.PubMedCrossRef
43.
Frontera JA, Lewin JJ, Rabinstein AA, et al. Guideline for reversal of antithrombotics in intracranial hemorrhage: a statement for healthcare professionals from the Neurocritical Care Society and Society of Critical Care Medicine. Neurocrit Care. 2016;24(1):6–46.PubMedCrossRef
44.
Glauser T, Shinnar S, Gloss D, et al. Evidence-based guideline: treatment of convulsive status epilepticus in children and adults: report of the guideline committee of the American Epilepsy Society. Epilepsy Curr. 2016;16(1):48–61.PubMedPubMedCentralCrossRef
45.
Harris D, Hall C, Lobay K, et al. Canadian Association of Emergency Physicians position statement on acute ischemic stroke. Cjem. 2015;17(2):217–26.PubMedCrossRef
46.
Hemphill JC, Adeoye OM, Alexander DN, et al. Clinical performance measures for adults hospitalized with intracerebral hemorrhage: performance measures for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2018;49(7):e243–61.PubMedCrossRef
47.
Hofmeijer J, Kappelle LJ, Algra A, et al. Surgical decompression for space-occupying cerebral infarction (the Hemicraniectomy After Middle Cerebral Artery infarction with Life-threatening Edema Trial [HAMLET]): a multicentre, open, randomised trial. Lancet Neurol. 2009;8(4):326–33.PubMedCrossRef
48.
Howes D, Gray SH, Brooks SC, et al. Canadian Guidelines for the use of targeted temperature management (therapeutic hypothermia) after cardiac arrest: a joint statement from The Canadian Critical Care Society (CCCS), Canadian Neurocritical Care Society (CNCCS), and the Canadian Critical Care Trials Group (CCCTG). Resuscitation. 2016;98:48–63.PubMedCrossRef
49.
Hughes RA, Brassington R, Gunn AA, van Doorn PA. Corticosteroids for Guillain-Barre syndrome. Cochrane Database Syst Rev. 2016;10:CD001446.PubMed
50.
Hughes RA, Swan AV, van Doorn PA. Intravenous immunoglobulin for Guillain-Barre syndrome. Cochrane Database Syst Rev. 2014;9:CD002063.
51.
Hughes RA, Wijdicks EF, Barohn R, et al. Practice parameter: immunotherapy for Guillain–Barre syndrome: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2003;61(6):736–40.PubMedCrossRef
52.
Hypothermia after Cardiac Arrest Study Group. Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest. N Engl J Med. 2002;346(8):549–56.CrossRef
53.
Jauch EC, Saver JL, Adams HP, et al. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2013;44(3):870–947.PubMedCrossRef
54.
Jouan Y, Grammatico-Guillon L, Espitalier F, et al. Long-term outcome of severe herpes simplex encephalitis: a population-based observational study. Crit Care. 2015;19:345.PubMedPubMedCentralCrossRef
55.
Juttler E, Schwab S, Schmiedek P, et al. Decompressive Surgery for the Treatment of Malignant Infarction of the Middle Cerebral Artery (DESTINY): a randomized, controlled trial. Stroke. 2007;38(9):2518–25.PubMedCrossRef
56.
Lange MC, Braga GP, Novak EM, et al. Key performance indicators for stroke from the Ministry of Health of Brazil: benchmarking and indicator parameters. Arq Neuropsiquiatr. 2017;75(6):354–8.PubMedCrossRef
57.
Lansberg MG, O’Donnell MJ, Khatri P, et al. Antithrombotic and thrombolytic therapy for ischemic stroke: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012;141(2 Suppl):e601S–36S.PubMedPubMedCentralCrossRef
58.
Leifer D, Bravata DM, Connors JJ 3rd, et al. Metrics for measuring quality of care in comprehensive stroke centers: detailed follow-up to Brain Attack Coalition comprehensive stroke center recommendations: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2011;42(3):849–77.PubMedCrossRef
59.
Lin TK, Lien LM, Chen WH, Huang SJ, Su CL. A concise guideline for the management of large hemispheric infarction in Taiwan: 2010 update: a guideline from the Taiwan Stroke Society. Acta Neurol Taiwan. 2010;19(4):296–302.PubMed
60.
Martins SC, Freitas GR, Pontes-Neto OM, et al. Guidelines for acute ischemic stroke treatment: part II: stroke treatment. Arq Neuropsiquiatr. 2012;70(11):885–93.PubMedCrossRef
61.
Mauri Llerda JA, Suller Marti A, de la Pena Mayor P, et al. The Spanish Society of Neurology’s official clinical practice guidelines for epilepsy. Special considerations in epilepsy: comorbidities, women of childbearing age, and elderly patients. Neurologia. 2015;30(8):510–7.PubMedCrossRef
62.
McGill F, Heyderman RS, Michael BD, et al. The UK joint specialist societies guideline on the diagnosis and management of acute meningitis and meningococcal sepsis in immunocompetent adults. J Infect. 2016;72(4):405–38.PubMedCrossRef
63.
McTaggart RA, Ansari SA, Goyal M, et al. Initial hospital management of patients with emergent large vessel occlusion (ELVO): report of the standards and guidelines committee of the Society of NeuroInterventional Surgery. J Neurointerv Surg. 2017;9(3):316–23.PubMedCrossRef
64.
65.
Meierkord H, Boon P, Engelsen B, et al. EFNS guideline on the management of status epilepticus in adults. Eur J Neurol. 2010;17(3):348–55.PubMedCrossRef
66.
Michel P, Arnold M, Hungerbuhler HJ, et al. Decompressive craniectomy for space occupying hemispheric and cerebellar ischemic strokes: Swiss recommendations. Int J Stroke. 2009;4(3):218–23.PubMedCrossRef
67.
Minematsu K, Toyoda K, Hirano T, et al. Guidelines for the intravenous application of recombinant tissue-type plasminogen activator (alteplase), the second edition, October 2012: a guideline from the Japan Stroke Society. J Stroke Cerebrovasc Dis. 2013;22(5):571–600.PubMedCrossRef
68.
Minicucci F, Muscas G, Perucca E, et al. Treatment of status epilepticus in adults: guidelines of the Italian League against Epilepsy. Epilepsia. 2006;47(Suppl 5):9–15.PubMedCrossRef
69.
National Institute for Health and Care Excellence, N.N. Tuberculosis: prevention, diagnosis, managment and service organization. London: National Institute for Health and Care Excellence; 2016.
70.
71.
72.
Nielsen N, Wetterslev J, Cronberg T, et al. Targeted temperature management at 33 degrees C versus 36 degrees C after cardiac arrest. N Engl J Med. 2013;369(23):2197–206.PubMedCrossRef
73.
Norrving B, Bray BD, Asplund K, et al. Cross-national key performance measures of the quality of acute stroke care in Western Europe. Stroke. 2015;46(10):2891–5.PubMedCrossRef
74.
Nyquist P, Bautista C, Jichici D, et al. Prophylaxis of venous thrombosis in neurocritical care patients: an evidence-based guideline: a statement for healthcare professionals from the Neurocritical Care Society. Neurocrit Care. 2016;24(1):47–60.PubMedCrossRef
75.
O’Brien JJ, Campoli-Richards DM. Acyclovir. An updated review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy. Drugs. 1989;37(3):233–309.PubMedCrossRef
76.
Pastores SM, Annane D, Rochwerg B. Guidelines for the diagnosis and management of critical illness-related corticosteroid insufficiency (CIRCI) in Critically Ill Patients (Part II): society of Critical Care Medicine (SCCM) and European Society of Intensive Care Medicine (ESICM) 2017. Crit Care Med. 2018;46(1):146–8.PubMedCrossRef
77.
Patwa HS, Chaudhry V, Katzberg H, Rae-Grant AD, So YT. Evidence-based guideline: intravenous immunoglobulin in the treatment of neuromuscular disorders: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology. 2012;78(13):1009–15.PubMedCrossRef
78.
Powers WJ, Derdeyn CP, Biller J, et al. 2015 American Heart Association/American Stroke Association focused update of the 2013 guidelines for the early management of patients with acute ischemic stroke regarding endovascular treatment: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2015;46(10):3020–35.PubMedCrossRef
79.
Powers WJ, Rabinstein AA, Ackerson T, et al. 2018 guidelines for the early management of patients with acute ischemic stroke: a guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke. 2018;49(3):e46–110.PubMedCrossRef
80.
Prasad K, Singh MB, Ryan H. Corticosteroids for managing tuberculous meningitis. Cochrane Database Syst Rev. 2016;4:CD002244.PubMed
81.
Roberts I, Yates D, Sandercock P, et al. Effect of intravenous corticosteroids on death within 14 days in 10008 adults with clinically significant head injury (MRC CRASH trial): randomised placebo-controlled trial. Lancet. 2004;364(9442):1321–8.PubMedCrossRef
82.
Schwartz J, Padmanabhan A, Aqui N, et al. Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the writing committee of the American Society for Apheresis: the seventh special issue. J Clin Apher. 2016;31(3):149–62.PubMed
83.
Schwartz J, Winters JL, Padmanabhan A, et al. Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the Writing Committee of the American Society for Apheresis: the sixth special issue. J Clin Apher. 2013;28(3):145–284.PubMedCrossRef
84.
Sejvar JJ, Baughman AL, Wise M, Morgan OW. Population incidence of Guillain–Barre syndrome: a systematic review and meta-analysis. Neuroepidemiology. 2011;36(2):123–33.PubMedCrossRef
85.
Skeie GO, Apostolski S, Evoli A, et al. Guidelines for the treatment of autoimmune neuromuscular transmission disorders. Eur J Neurol. 2006;13(7):691–9.PubMedCrossRef
86.
Skoldenberg B, Forsgren M, Alestig K, et al. Acyclovir versus vidarabine in herpes simplex encephalitis. Randomised multicentre study in consecutive Swedish patients. Lancet. 1984;2(8405):707–11.PubMedCrossRef
87.
Smith EE, Saver JL, Alexander DN, et al. Clinical performance measures for adults hospitalized with acute ischemic stroke: performance measures for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2014;45(11):3472–98.PubMedCrossRef
88.
Solomon T, Michael BD, Smith PE, et al. Management of suspected viral encephalitis in adults–Association of British Neurologists and British Infection Association National Guidelines. J Infect. 2012;64(4):347–73.PubMedCrossRef
89.
Solter VV, Roje-Bedekovic M, Breitenfeld T, et al. Recommendations for the management of medical complications in patients following aneurysmal subarachnoid hemorrhage. Acta Clin Croat. 2014;53(1):113–38.PubMed
90.
Steiner I, Budka H, Chaudhuri A, et al. Viral meningoencephalitis: a review of diagnostic methods and guidelines for management. Eur J Neurol. 2010;17(8):999-e57.PubMedCrossRef
91.
Steiner T, Juvela S, Unterberg A, et al. European Stroke Organization guidelines for the management of intracranial aneurysms and subarachnoid haemorrhage. Cerebrovasc Dis. 2013;35(2):93–112.PubMedCrossRef
92.
Suarez JI. Diagnosis and management of subarachnoid hemorrhage. Continuum (Minneap Minn). 2015;21(5 Neurocritical Care):1263–87.
93.
Tallarico RT, Pizzi MA, Freeman WD. Investigational drugs for vasospasm after subarachnoid hemorrhage. Expert Opin Investig Drugs. 2018;27(4):313–24.PubMedCrossRef
94.
95.
96.
Thwaites G, Fisher M, Hemingway C, et al. British Infection Society guidelines for the diagnosis and treatment of tuberculosis of the central nervous system in adults and children. J Infect. 2009;59(3):167–87.PubMedCrossRef
97.
Tunkel AR, Glaser CA, Bloch KC, et al. The management of encephalitis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2008;47(3):303–27.PubMedCrossRef
98.
Tunkel AR, Hartman BJ, Kaplan SL, et al. Practice guidelines for the management of bacterial meningitis. Clin Infect Dis Offic Publ Infect Dis Soc Am. 2004;39(9):1267–84.CrossRef
99.
Tunkel AR, Hasbun R, Bhimraj A, et al. Infectious Diseases Society of America’s clinical practice guidelines for healthcare-associated ventriculitis and meningitis. Clin Infect Dis. 2017;64:e34–65.PubMedPubMedCentralCrossRef
100.
Vahedi K, Vicaut E, Mateo J, et al. Sequential-design, multicenter, randomized, controlled trial of early decompressive craniectomy in malignant middle cerebral artery infarction (DECIMAL Trial). Stroke. 2007;38(9):2506–17.PubMedCrossRef
101.
van de Beek D, Cabellos C, Dzupova O, et al. ESCMID guideline: diagnosis and treatment of acute bacterial meningitis. Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis. 2016;22(Suppl 3):S37–62.
102.
Venketasubramanian N, Pwee KH, Chen CP. Singapore Ministry of Health Clinical practice guidelines workgroup on, S. Transient ischaemic, A. Singapore ministry of health clinical practice guidelines on stroke and transient ischemic attacks. Int J Stroke. 2011;6(3):251–8.PubMedCrossRef
103.
Vivancos J, Gilo F, Frutos R, et al. Clinical management guidelines for subarachnoid haemorrhage. Diagnosis and treatment. Neurologia. 2014;29(6):353–70.PubMedCrossRef
104.
Whitley RJ, Alford CA, Hirsch MS, et al. Vidarabine versus acyclovir therapy in herpes simplex encephalitis. N Engl J Med. 1986;314(3):144–9.PubMedCrossRef
105.
106.
Wijdicks EF, Sheth KN, Carter BS, et al. Recommendations for the management of cerebral and cerebellar infarction with swelling: a statement for healthcare professionals from the american heart association/american stroke association. Stroke. 2014;45(4):1222–38.PubMedCrossRef
107.
108.
Wong GC, van Diepen S, Ainsworth C, et al. Canadian Cardiovascular Society/Canadian Cardiovascular Critical Care Society/Canadian Association of interventional cardiology position statement on the optimal care of the postarrest patient. Can J Cardiol. 2017;33(1):1–16.PubMedCrossRef
109.
Xu AD, Wang YJ, Wang DZ. Chinese stroke therapy expert panel for intravenous recombinant tissue plasminogen, A. consensus statement on the use of intravenous recombinant tissue plasminogen activator to treat acute ischemic stroke by the Chinese Stroke Therapy Expert Panel. CNS Neurosci Ther. 2013;19(8):543–8.PubMedPubMedCentralCrossRef
Metadata
Title
Clinical Performance Measures for Neurocritical Care: A Statement for Healthcare Professionals from the Neurocritical Care Society
Authors
Sarah Livesay
Herbert Fried
David Gagnon
Navaz Karanja
Abhijit Lele
Asma Moheet
Casey Olm-Shipman
Fabio Taccone
David Tirschwell
Wendy Wright
J. Claude Hemphill III
the Neurocritical Care Society
Publication date
01-02-2020
Publisher
Springer US
Keyword
Care
Published in
Neurocritical Care / Issue 1/2020
Print ISSN: 1541-6933
Electronic ISSN: 1556-0961
DOI
https://doi.org/10.1007/s12028-019-00846-w

Other articles of this Issue 1/2020

Neurocritical Care 1/2020 Go to the issue

Practical Pearl

Reversible Cerebral Vasoconstriction Syndrome Responsive to Intravenous Milrinone

Original Work

Worldwide Organization of Neurocritical Care: Results from the PRINCE Study Part 1

News

Reviewer Thanks

Original Work

Safety and Tolerability of Rapid Administration Undiluted Levetiracetam

Review Article

Collaborative Management Strategies for Drug Shortages in Neurocritical Care

Proceedings

The Future of Neurocritical Care Research: Proceedings and Recommendations from the Fifth Neurocritical Care Research Network Conference